In order to determine whether the high ATG9A mRNA levels quantified in TN tumors were a cause or a consequence of tumor development, we decided to inhibit ATG9A expression in the TNBC cell line MDA-MB-436. The gene discussed is ATG9A; the disease is neoplasm.